Introduction: MS-dependent covalent binding assays precisely evaluate Kinact and Ki kinetics, enabling higher-throughput analysis of inhibitor potency and binding speed critical for covalent drug improvement. Every drug discovery scientist is aware of the irritation of encountering ambiguous facts when evaluating inhibitor potency. When creating c